Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced the issuance of 4 million unquoted options expiring in April 2026, with an exercise price of $0.207 each, effective from April 10, 2024. These securities are part of a transaction previously disclosed to the market and will not be quoted on the ASX.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
